Pain News and Research

Latest Pain News and Research

Low-level laser therapy increases tumour growth in skin cancer

High irradiances of low-level laser therapy (LLLT) should not be used over melanomas. Researchers writing in the open access journal BMC Cancer studied the pain relieving, anti-inflammatory 'cold laser', finding that it caused increased tumour growth in a mouse model of skin cancer.

19 Nov 2009

Canadian Arthritis Network to host 2009 Annual Scientific Conference in Vancouver

People with arthritis and leading Canadian and international researchers will share the stage under the theme "Decoding Arthritis - A Joint Effort" when the Canadian Arthritis Network (CAN) hosts its 2009 Annual Scientific Conference beginning tonight, in Vancouver, BC.

19 Nov 2009

The Community Hospice sets up social community site to raise awareness on hospice care

The Community Hospice, one of the largest and most established hospice organizations in the nation, will premiere its online "Quality of Life, Not End of Life" program on December 10 at Noon ET. The goal is to raise awareness of the many benefits of hospice care for both patients and their family members.

19 Nov 2009

System to help identify patients at high risk of developing delirium

A specialist in caring for elderly patients, Turner-Hubbard is a geriatric nurse practitioner trained to quickly spot the sudden changes in mental status that signal the onset of the sudden, severe confusion known as delirium. She knows the hospital “triggers” that can bring on fluctuations in behavior: blood loss during surgery, anesthesia, pain medications and anti-anxiety drugs, infections, dehydration, IV lines and catheters, as well as being immobilized for an extended period of time.

19 Nov 2009

Six new degree programs to be offered by High-Tech Institute in Minneapolis

High-Tech Institute in Minneapolis will begin offering six new degree programs, with a class start set for January 11, 2010 for all programs. The school is located at 5100 Gamble Drive, Suite 200 in St. Louis Park, Minn.

19 Nov 2009

Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

While fewer teens are drinking alcohol in 2009 than a decade ago, binge drinking, use of cannabis and prescription drugs remain a concern, according to the 2009 Ontario Student Drug Use and Health Survey (OSDUHS) released today by the Centre for Addiction and Mental Health.

19 Nov 2009

Study: EP4 agonist may reduce gastric bleeding and inflammation

Over 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in the world to treat pain, arthritis, fever and other diseases. Nearly 30% of the users suffer from gastric lesions and bleeding.

19 Nov 2009

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking.

19 Nov 2009

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

Today, Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries.

19 Nov 2009

Opiate-based painkillers can increase tumor-cell proliferation, says new study

Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.

19 Nov 2009

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.

19 Nov 2009

Once-a-day dosing clinical study of udenafil for erectile dysfunction completed

Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).

19 Nov 2009

Tips for staying safe and healthy during Thanksgiving holiday

Visiting is a big part of the Thanksgiving holiday. But one place you don't want to stop by is the Emergency Department.

19 Nov 2009

Tips for lessening needle anxiety

Experts believe fear of needles may be preventing people from rolling up their sleeves for the H1N1 vaccination.

18 Nov 2009

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.

18 Nov 2009

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash.

18 Nov 2009

Recent data from CNSBio's Phase IIa CNSB015 trial to be presented at the Neuropathic Pain conference

CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA.

18 Nov 2009

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Clinical Data, Inc. today announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze™, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze (apadenoson) for use as a pharmacologic stress agent in myocardial perfusion imaging (MPI), a method for detecting defects in the blood supply to the heart.

18 Nov 2009

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model.

18 Nov 2009

New source of information can help prescribers and patients in understanding anticipated side effects of treatments

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information.

18 Nov 2009

Pain News and Research

Latest Pain News and Research

Low-level laser therapy increases tumour growth in skin cancer

Canadian Arthritis Network to host 2009 Annual Scientific Conference in Vancouver

The Community Hospice sets up social community site to raise awareness on hospice care

System to help identify patients at high risk of developing delirium

Six new degree programs to be offered by High-Tech Institute in Minneapolis

Binge drinking, cannabis and prescription drugs still remain a concern among teenagers

Study: EP4 agonist may reduce gastric bleeding and inflammation

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

Opiate-based painkillers can increase tumor-cell proliferation, says new study

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

Once-a-day dosing clinical study of udenafil for erectile dysfunction completed

Tips for staying safe and healthy during Thanksgiving holiday

Tips for lessening needle anxiety

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Recent data from CNSBio's Phase IIa CNSB015 trial to be presented at the Neuropathic Pain conference

Clinical Data commences patient enrollment in Stedivaze Phase III trial

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

New source of information can help prescribers and patients in understanding anticipated side effects of treatments

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in